• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5073861)   Today's Articles (184)
For: Muhandiramge J, Lee V, Tran M, Ho L. Interaction between ferric carboxymaltose and denosumab causing severe hypocalcaemia and hypophosphataemia in a patient without chronic kidney disease. Intern Med J 2023;53:1273-1276. [PMID: 37384573 DOI: 10.1111/imj.16156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Accepted: 04/25/2023] [Indexed: 07/01/2023]
Number Cited by Other Article(s)
1
Pak LMK, Cox A, Bach LA. Symptomatic hypocalcaemia after administration of denosumab and iron infusion in patients with normal and impaired renal function. Intern Med J 2025. [PMID: 40423532 DOI: 10.1111/imj.70091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2024] [Accepted: 04/15/2025] [Indexed: 05/28/2025]
2
Ye S, Grill V, Luo J, Nguyen HH. Concurrent Denosumab and Parenteral Iron Therapy Precipitating Severe Hypocalcemia and Hypophosphatemia. JCEM CASE REPORTS 2024;2:luae005. [PMID: 38304007 PMCID: PMC10833138 DOI: 10.1210/jcemcr/luae005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Indexed: 02/03/2024]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA